For Industry

The Voice of the Patient: A Series of Reports from FDA's Patient-Focused Drug Development Initiative

Under the fifth authorization of the Prescription Drug User Fee Act (PDUFA V), FDA conducted 24 disease-specific Patient-Focused Drug Development (PFDD) meetings to more systematically gather patients’ perspectives on their condition and available therapies to treat their condition. The Voice of the Patient reports summarize the input provided by patients and patient representatives at each of these public meetings.

The Voice of the Patient Reports

Page Last Updated: 04/17/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English